September 18, 2014
Wall Street Journal interviews Judy Wylie-Rosett, Ph.D., about research that suggests artificial sweeteners may raise blood sugar levels by altering the body’s gut bacteria. Dr. Wylie-Rosett notes that the study is important since it is the first to examine how gut microbes contribute to processing real and fake sugars. Dr. Wylie-Rosett is head of the division of health promotion and nutrition research, and professor of epidemiology & population health and of medicine at Einstein.
Dr. Rosett's ProfileMore coverage on Dr. Rosett
September 15, 2014
Nature interviews Dean Hosgood, Ph.D., M.P.H, about his research on the environmental and genetic factors that lead to high rates of lung cancer in non-smoking Asian women. Dr. Hosgood notes that as smoking decreases, other factors will become a larger proportion of lung cancer cases, so investigating this phenomenon can help the wider population. Dr. Hosgood is assistant professor of epidemiology & population health.
Dr. Hosgood's Profile
September 9, 2014
CBSNews.com interviews Lisa Shulman, M.D., about a promising autism intervention program that helped resolve autism behaviors in the majority of 7-to-15-month-olds studied. Dr. Shulman calls the study “groundbreaking” and also outlines a few key behaviors parents should look out for, such as fixating for long periods on objects rather than faces. Dr. Shulman is associate professor of clinical pediatrics and director of infant and toddler services at Einstein’s Children’s Evaluation and Rehabilitation Center and an attending physician at The Children’s Hospital at Montefiore.
More CoverageDr. Shulman's ProfileMore coverage on Dr. Shulman
September 4, 2014
The Washington Post interviews Richard Lipton, M.D., about why more women than men develop Alzheimer’s disease. Research from Dr. Lipton’s Einstein Aging Study found that women, ages 70 to 79, were more than twice as likely to develop Alzheimer’s or other forms of dementia as men of the same age, but that after the age of 80 the risk is similar for both genders. Dr. Lipton is director of the Einstein Aging Study and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the division of cognitive aging and dementia at Montefiore Medical Center.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
September 2, 2014
New York Times interviews Kartik Chandran, Ph.D., about new research that found the experimental Ebola drug ZMapp was successful in treating monkeys infected with the virus. The drug was used to treat two American aid workers infected during the current West African outbreak. Dr. Chandran notes the preliminary results were astounding as following treatment all the monkeys were healthy. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology
Dr. Chandran's ProfileMore coverage on Dr. Chandran
August 29, 2014
New York Times interviews Kami Kim, M.D., about research that finds the parasite Toxoplasma gondii can manipulate the behavior of its host by switching on genes in brain cells. Research by Dr. Kim has found that a number of pathogens, including leprosy, appear to use DNA methylation to turn genes on and off in the animal it infects. Dr. Kim is professor medicine, of microbiology & immunology and of pathology.
Dr. Kim's ProfileMore coverage on Dr. Kim
August 27, 2014
CBSNews.com interviews Michael Lipton, M.D., Ph.D., about the FDA consumer alert for dietary supplements that falsely claim to prevent or cure concussions. Dr. Lipton notes that such claims may lead people to be less careful than they should and that the best way to prevent a concussion is to not have a head injury. Dr. Lipton is associate professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein and medical director of MRI services at Montefiore Medical Center.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
August 19, 2014
NY1 interviews Jonathan Lai, Ph.D., about his research on Ebola that focuses on developing antibodies to use as a possible treatment for all five strains of the virus. Dr. Lai notes that so far his lab has discovered antibodies that have proven protective in mice against the Sudan strain of the Ebola virus, but more research is required. Dr. Lai is associate professor of biochemistry.
More CoverageDr. Lai's ProfileMore coverage on Dr. Lai
August 15, 2014
USA Today interviews Belinda Ostrowsky, M.D., about rapid detection tests for Ebola that are in development. The fastest reliable tests for Ebola currently take about three days, which can delay treatment. Dr. Ostrowsky notes that any rapid detection method would benefit patients and healthcare providers. Dr. Ostrowsky is associate professor of clinical medicine at Einstein and director of the Einstein-Montefiore Antibiotic Stewardship Program.
Dr. Ostrowsky's ProfileMore coverage on Dr. Ostrowsky
August 13, 2014
NPR’s Morning Edition interviews Arturo Casadevall, M.D., Ph.D., on the controversy surrounding research on dangerous lab-made pathogens. Following the mishandling of smallpox by the CDC, the potential exposure of CDC scientists to live anthrax and even the recent the spread of Ebola, biologists and others are calling on the National Academy of Sciences to provide guidance on when and under what conditions research using lab-manipulated pathogens should be allowed to move forward. Dr. Casadevall is professor and chair of microbiology & immunology and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein. (Dr. Casadevall’s interview begins at 4:38 in the audio version)
Dr. Casadevall's ProfileMore coverage on Dr. Casadevall
August 6, 2014
NBC News interviews Arturo Casadevall, M.D., Ph.D., about the history of using serums and antibodies to combat disease in light of an experimental Ebola treatment. Dr. Casadevall notes that antibody treatments, which are most known for fighting infectious diseases, have also had an enormous impact on treating certain cancers, such as breast and colon cancer. Dr. Casadevall is professor and chair of microbiology & immunology and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.
More CoverageDr. Casadevall's ProfileMore coverage on Dr. Casadevall
August 5, 2014
CBSNews.com interviews Kartik Chandran, Ph.D., about the Ebola outbreak and his research on the virus. Dr. Chandran explains how Ebola enters cells and that his and other scientists’ research has identified new targets for drug development. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology.
More CoverageDr. Chandran's ProfileMore coverage on Dr. Chandran
August 5, 2014
The Washington Post reports on research by Joe Verghese, M.B.B.S., that predicts pre-dementia by measuring walking speed and cognitive abilities. The quick, low-tech test determined that 1 in 10 older adults have pre-dementia. The study involved 27,000 people in 7 countries. It found that those who had unusually slow walking speed and cognitive complaints are twice as likely to develop dementia within 12 years. Dr. Verghese is professor of neurology at Einstein and chief of the division of geriatrics at Einstein and Montefiore Medical Center.
More CoverageDr. Verghese's ProfileMore coverage on Dr. Verghese
August 1, 2014
ABC-TV’s “Good Morning America” interviews Keith Ayoob, Ed.D., about a new CDC report that found nearly 25 percent of parents underestimate their children’s weight. The study also found that 27 percent of children and teens underestimate their own weight. Dr. Ayoob notes parents often believe that their children will outgrow being overweight, which is unlikely, and cautions against waiting to make dietary and lifestyle changes. Dr. Ayoob is associate clinical professor of pediatrics and director of the nutrition clinic at the Children's Evaluation and Rehabilitation Center at Einstein.
Dr. Ayoob's ProfileMore coverage on Dr. Ayoob